ArticleAdvances in therapy2023

Budget Impact Analysis of REBYOTA™ (Fecal Microbiota, Live-jslm [FMBL]) for Preventing Recurrent Clostridioides difficile Infection in the US.

Thomas Lodise et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.